Technical Analysis for 4BB - 4basebio PLC
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 1070.00 | -4.46% | -50.00 |
4BB closed down 4.46 percent on Friday, April 26, 2024, on 75 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Jack-in-the-Box Bullish | Bullish Swing Setup | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
New 52 Week Closing High | Bullish | -4.46% | |
180 Bullish Setup | Bullish Swing Setup | -4.46% | |
Expansion Breakout | Bullish Swing Setup | -4.46% | |
Pocket Pivot | Bullish Swing Setup | -4.46% | |
Reversal New Highs Setup | Bullish Swing Setup | -4.46% | |
Slingshot Bullish | Bullish Swing Setup | -4.46% |
Alert | Time |
---|---|
Possible Inside Day | 1 day ago |
Down 3% | 1 day ago |
Down 2% | 1 day ago |
Down 1 ATR | 1 day ago |
1.5x Volume Pace | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Classification
Sector: Healthcare
Industry: Biotechnology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1120.0 |
52 Week Low | 492.0 |
Average Volume | 3,005 |
200-Day Moving Average | 682.73 |
50-Day Moving Average | 922.90 |
20-Day Moving Average | 1003.25 |
10-Day Moving Average | 1057.50 |
Average True Range | 41.03 |
RSI (14) | 65.03 |
ADX | 44.86 |
+DI | 22.26 |
-DI | 8.11 |
Chandelier Exit (Long, 3 ATRs) | 996.92 |
Chandelier Exit (Short, 3 ATRs) | 1024.08 |
Upper Bollinger Bands | 1123.05 |
Lower Bollinger Band | 883.45 |
Percent B (%b) | 0.78 |
BandWidth | 23.88 |
MACD Line | 44.95 |
MACD Signal Line | 40.95 |
MACD Histogram | 3.9991 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1113.50 | ||||
Resistance 3 (R3) | 1118.33 | 1108.67 | 1106.25 | ||
Resistance 2 (R2) | 1108.67 | 1097.59 | 1106.25 | 1103.83 | |
Resistance 1 (R1) | 1089.33 | 1090.74 | 1084.50 | 1084.50 | 1101.42 |
Pivot Point | 1079.67 | 1079.67 | 1077.25 | 1077.25 | 1079.67 |
Support 1 (S1) | 1060.33 | 1068.59 | 1055.50 | 1055.50 | 1038.58 |
Support 2 (S2) | 1050.67 | 1061.74 | 1048.25 | 1036.17 | |
Support 3 (S3) | 1031.33 | 1050.67 | 1033.75 | ||
Support 4 (S4) | 1026.50 |